Delivery Order SPE2DR25D3019-SPE2DR26FK4ET
Award Date 12/30/25
Potential Completion Date 12/31/25
Potential Value $26K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $44,057.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injector pens on December 11, 2025, with an ultimate completion date of December 12, 2025. This non-set-aside contract represents a competitive award to the prime contractor, which is headquartered in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $14,080.56 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injector pens, with a completion date of November 17, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, PA. This delivery order represents a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,776.39 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injector pens, with a completion date of December 10, 2025. The contract utilized firm fixed pricing under a non-competitive delivery order, with the place of performance located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This award represents a single delivery order executed under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $3,223.99 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injector pens, with an ultimate completion date of December 23, 2025. This non-competitive, firm fixed-price delivery order was issued on December 22, 2025, and will be performed at the contractor's corporate headquarters in Conshohocken, Pennsylvania. REPATHA is a PCSK9 inhibitor indicated for cardiovascular disease management, representing part of the...
- The Defense Logistics Agency awarded a delivery order valued at $46,199.30 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injector pens, with completion scheduled for August 29, 2025. This is a firm fixed-price, non-set-aside contract executed on August 28, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. REPATHA is a PCSK9 inhibitor used to treat high cholesterol and reduce cardiovascular risk in eligible patient...
- The Defense Logistics Agency (DLA) awarded a $88,817.52 delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injector pens, with an ultimate completion date of December 17, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a continuation order under AmerisourceBergen's larger pharmaceutical supply relationship with the federal government. The place of performance is listed as Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $22,002.23 delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injector pens, with an ultimate completion date of October 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. REPATHA (evolocumab) is a PCSK9 inhibitor used in cardiovascular disease...
- The Defense Logistics Agency awarded a $16,007.47 delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/mL SureClick auto-injectors, with an ultimate completion date of September 2, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is issued under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a delivery order valued at $11,276.07 to AmerisourceBergen Drug Corp for REPATHA 140 MG/ML SureClick auto-injectors. This firm fixed-price, competitively awarded contract (No. 4570376219) is scheduled for completion by December 31, 2025, with the award issued on December 30, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. REPATHA is a prescription medication used to treat high cholesterol and...
- The Defense Logistics Agency awarded a delivery order valued at $2,392.50 to AmerisourceBergen Drug Corp for REPATHA 140 MG/ML SureClick auto-injector pens, with an ultimate completion date of October 23, 2025. This is a firm fixed price delivery order with no set-aside designation, performed at the contractor's Conshohocken, Pennsylvania location. The award represents a single transaction under AmerisourceBergen's larger pharmaceutical supply vehicle with the DLA. This delivery order falls...